Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

1.

Comparative transcriptomic analysis between an artificially induced SIRS in healthy individuals and spontaneous sepsis.

Monteiro Sousa C, Boissel JP, Gueyffier F, Olivera-Botello G.

C R Biol. 2015 Aug 11. pii: S1631-0691(15)00119-5. doi: 10.1016/j.crvi.2015.05.001. [Epub ahead of print]

PMID:
26276539
2.

[ECRIN Standard Requirements for Good Clinical Practices-compliant Data Management in Multinational Clinical Trials].

Cornu C, Donche A, Coffre C, Le Gouge A, Rym B, Vaugier I, Barbot F, Leizorovicz A, Juge N, Giraud C, Gueyffier F, Félin A, Mura T, Chevassus H, Binquet C; le Comité de Pilotage du groupe de travail Harmonisation des procédures de réseau des CIC.

Therapie. 2015 Aug 3. [Epub ahead of print] French.

PMID:
26238126
3.

Different treatment benefits were estimated by clinical trials performed in adults compared with those performed in children.

Janiaud P, Lajoinie A, Cour-Andlauer F, Cornu C, Cochat P, Cucherat M, Gueyffier F, Kassai B.

J Clin Epidemiol. 2015 Jul 9. pii: S0895-4356(15)00334-0. doi: 10.1016/j.jclinepi.2015.06.021. [Epub ahead of print] Review.

PMID:
26164751
4.

Multivariate meta-analysis using individual participant data.

Riley RD, Price MJ, Jackson D, Wardle M, Gueyffier F, Wang J, Staessen JA, White IR.

Res Synth Methods. 2015 Jun;6(2):157-74. doi: 10.1002/jrsm.1129. Epub 2014 Nov 21.

PMID:
26099484
5.

Meta-analysis of a continuous outcome combining individual patient data and aggregate data: a method based on simulated individual patient data.

Yamaguchi Y, Sakamoto W, Goto M, Staessen JA, Wang J, Gueyffier F, Riley RD.

Res Synth Methods. 2014 Dec;5(4):322-51. doi: 10.1002/jrsm.1119. Epub 2014 Jun 9.

PMID:
26052956
6.

Is HbA1c a valid surrogate for macrovascular and microvascular complications in type 2 diabetes?

Bejan-Angoulvant T, Cornu C, Archambault P, Tudrej B, Audier P, Brabant Y, Gueyffier F, Boussageon R.

Diabetes Metab. 2015 Jun;41(3):195-201. doi: 10.1016/j.diabet.2015.04.001. Epub 2015 May 6. Review.

PMID:
25958125
7.

Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study.

Vale CL, Rydzewska LH, Rovers MM, Emberson JR, Gueyffier F, Stewart LA; Cochrane IPD Meta-analysis Methods Group.

BMJ. 2015 Mar 6;350:h1088. doi: 10.1136/bmj.h1088.

8.

Translational research: precision medicine, personalized medicine, targeted therapies: marketing or science?

Marquet P, Longeray PH, Barlesi F; participants of round table N°1 of Giens XXX:, Ameye V, Augé P, Cazeneuve B, Chatelut E, Diaz I, Diviné M, Froguel P, Goni S, Gueyffier F, Hoog-Labouret N, Mourah S, Morin-Surroca M, Perche O, Perin-Dureau F, Pigeon M, Tisseau A, Verstuyft C.

Therapie. 2015 Jan-Feb;70(1):1-19. doi: 10.2515/therapie/2014231. Epub 2015 Feb 16. English, French.

PMID:
25679189
9.

Comparison of an effect-model-law-based method versus traditional clinical practice guidelines for optimal treatment decision-making: application to statin treatment in the French population.

Kahoul R, Gueyffier F, Amsallem E, Haugh M, Marchant I, Boissel FH, Boissel JP.

J R Soc Interface. 2014 Nov 6;11(100):20140867. doi: 10.1098/rsif.2014.0867.

PMID:
25209407
10.

The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial.

Lion-François L, Gueyffier F, Mercier C, Gérard D, Herbillon V, Kemlin I, Rodriguez D, Ginhoux T, Peyric E, Coutinho V, Bréant V, des Portes V, Pinson S, Combemale P, Kassaï B; Réseau NF1 Rhône Alpes Auvergne-France.

Orphanet J Rare Dis. 2014 Sep 10;9:142. doi: 10.1186/s13023-014-0142-4.

11.

Cardiovascular events and bleeding risk associated with intravitreal antivascular endothelial growth factor monoclonal antibodies: systematic review and meta-analysis.

Thulliez M, Angoulvant D, Le Lez ML, Jonville-Bera AP, Pisella PJ, Gueyffier F, Bejan-Angoulvant T.

JAMA Ophthalmol. 2014 Nov;132(11):1317-26. doi: 10.1001/jamaophthalmol.2014.2333. Review.

PMID:
25058694
12.

Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease.

Gaillard S, Dupuis-Girod S, Boutitie F, Rivière S, Morinière S, Hatron PY, Manfredi G, Kaminsky P, Capitaine AL, Roy P, Gueyffier F, Plauchu H; ATERO Study Group.

J Thromb Haemost. 2014 Sep;12(9):1494-502. doi: 10.1111/jth.12654. Epub 2014 Jul 29.

PMID:
25040799
13.

Guidelines for managing high blood pressure.

Cundiff DK, Gueyffier F, Wright JM.

JAMA. 2014 Jul 16;312(3):294. doi: 10.1001/jama.2014.6596. No abstract available.

PMID:
25027149
14.

Improving risk prediction performance for a better guidelines application.

Marchant I, Bejan-Angoulvant T, Le HH, Gueyffier F.

J Hypertens. 2014 Jun;32(6):1192-3. doi: 10.1097/HJH.0000000000000194. No abstract available.

PMID:
24781508
15.

Can we identify response markers to antihypertensive drugs? First results from the IDEAL Trial.

Gueyffier F, Subtil F, Bejan-Angoulvant T, Zerbib Y, Baguet JP, Boivin JM, Mercier A, Leftheriotis G, Gagnol JP, Fauvel JP, Giraud C, Bricca G, Maucort-Boulch D, Erpeldinger S; IDEAL Trial Group.

J Hum Hypertens. 2015 Jan;29(1):22-7. doi: 10.1038/jhh.2014.29. Epub 2014 Apr 17.

PMID:
24739801
16.

Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: what is the level of evidence?

Boussageon R, Gueyffier F, Cornu C.

Diabetes Metab. 2014 Jun;40(3):169-75. doi: 10.1016/j.diabet.2013.12.010. Epub 2014 Feb 3. Review.

17.

Impact of the reduction of calcineurin inhibitors on renal function in heart transplant patients: a systematic review and meta-analysis.

Cornu C, Dufays C, Gaillard S, Gueyffier F, Redonnet M, Sebbag L, Roussoulières A, Gleissner CA, Groetzner J, Lehmkuhl HB, Potena L, Gullestad L, Cantarovich M, Boissonnat P.

Br J Clin Pharmacol. 2014 Jul;78(1):24-32. doi: 10.1111/bcp.12289.

18.

Clinically relevant efficacy of insulin therapy in patients with type 2 diabetes.

Boussageon R, Gamble JM, Gueyffier F, Cornu C.

Therapie. 2013 Nov-Dec;68(6):415-7. doi: 10.2515/therapie/2013063. Epub 2013 Nov 11. No abstract available.

PMID:
24246125
19.

Are concomitant treatments confounding factors in randomized controlled trials on intensive blood-glucose control in type 2 diabetes? a systematic review.

Boussageon R, Supper I, Erpeldinger S, Cucherat M, Bejan-Angoulvant T, Kassai B, Cornu C, Gueyffier F.

BMC Med Res Methodol. 2013 Aug 30;13:107. doi: 10.1186/1471-2288-13-107. Review.

20.

Is there excess mortality in women screened with mammography: a meta-analysis of non-breast cancer mortality.

Erpeldinger S, Fayolle L, Boussageon R, Flori M, Lainé X, Moreau A, Gueyffier F.

Trials. 2013 Nov 5;14:368. doi: 10.1186/1745-6215-14-368. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk